What is "NQ Global Startup Gateway"?
The NQ Global Startup Gateway (Nakanoshima Qross Global Startup Creation & Hub Promotion Initiative), hosted by Osaka Prefecture, is a life-science startup aggregation and acceleration program aimed at establishing a globally competitive startup ecosystem and creating startups that can succeed worldwide. To firmly secure Nakanoshima Qross as an industrial hub for next-generation healthcare—beginning with regenerative medicine—the program strengthens the functions that attract and develop life-science startups, the driving force behind this goal.
For life-science startups, it is essential to plan for international expansion from the very outset of commercialization. This requires mentoring and funding from globally active accelerators, investors, and corporates to adapt their businesses to global markets. Accordingly, the initiative will offer Nakanoshima Qross–original development programs designed to cultivate globally active startups, while consolidating and enhancing the presence and capabilities of startup support organizations at Nakanoshima Qross.
By solidifying Nakanoshima Qross’s position as a hub for the industrialization of next-generation healthcare—and by building the brand promise that “at Nakanoshima Qross, ventures can commercialize quickly and reliably”—we will attract high-potential life-science startups from Japan and abroad, provide intensive hands-on support through Nakanoshima Qross’s dedicated programs, and build networks with overseas ecosystem partners to drive global expansion.
Implemented Programs
Global Accelerator Program
NQ Health Accelerator Program
Creating global startups through the provision of tailor-made startup support programs and overseas travel support programs. AstraZeneca, Cambridge Consultants, and MedTech Actuator collaborate on this program focused on overseas market development.
NQ version
COO HR Development Program
The “Nakanoshima Qross COO Development Program” is a talent-development initiative for Japan-based startups, adapted from 82VS Venture Studios (Alloy Therapeutics) and its COO (Chief Operating Officer) training program run for U.S. startups.
NQ version
Bio-Catalyst AI Accelerator Program
This program leverages Deep Intelligent Pharma’s cutting-edge AI and global domain expertise to transform promising startups into investor-ready companies.
Project Operator
Nakanoshima Cross Global Startup Creation and Location Promotion Project
Host / Osaka Prefectural Government
Operator /NQ Global Startup Gateway Joint Venture
AstraZeneca Corporation
Cambridge Consultants, Inc.
Medtec Actuator LLC
ALLOY THERAPEUTICS Co.
Deep Intelligent Pharma, Inc.
MIRACLE SCIENCE INNOVATION
Corporation (Representative Company)